These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7831243)

  • 41. Clinical use of fluoroquinolones in children.
    Alghasham AA; Nahata MC
    Ann Pharmacother; 2000 Mar; 34(3):347-59; quiz 413-4. PubMed ID: 10917383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Concentrations preventing resistance mutations against fluoroquinolones].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1807-9. PubMed ID: 12497723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and efficacy of the new quinolones in infections of the eye, ear, nose, and throat.
    Barza M
    Rev Infect Dis; 1988; 10 Suppl 1():S241-7. PubMed ID: 3279497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of newer fluoroquinolones in lower respiratory tract infections.
    Lode H; Allewelt M
    J Antimicrob Chemother; 2002 May; 49(5):709-12. PubMed ID: 12003962
    [No Abstract]   [Full Text] [Related]  

  • 45. Fluoroquinolones in paediatrics: a risk for the patient or for the community?
    Gendrel D; Chalumeau M; Moulin F; Raymond J
    Lancet Infect Dis; 2003 Sep; 3(9):537-46. PubMed ID: 12954559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic and clinical studies of T-3761 in otorhinolaryngeal infections.
    Shinkawa A; Kimura H; Sakai M; Miyake H
    Drugs; 1995; 49 Suppl 2():401-2. PubMed ID: 8549377
    [No Abstract]   [Full Text] [Related]  

  • 47. [Latest news on fluoroquinolones].
    Bergogne-Bérézin E
    Presse Med; 2002 Nov; 31(38):1805-6. PubMed ID: 12497722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoroquinolones in paediatrics.
    Gendrel D; Moulin F
    Paediatr Drugs; 2001; 3(5):365-77. PubMed ID: 11393329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antichlamydial activities of newly developed fluoroquinolones and their potential future role in the treatment of chlamydial respiratory infections.
    Soejima R; Niki Y; Kishomoto T; Kimura M; Kubota Y
    Drugs; 1995; 49 Suppl 2():257-9. PubMed ID: 8549323
    [No Abstract]   [Full Text] [Related]  

  • 50. The appropriate use of quinolones.
    Percival A
    Drugs; 1996; 52 Suppl 2():34-6. PubMed ID: 8869834
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of fluoroquinolones in the treatment of skin infections.
    Martin SJ; Zeigler DG
    Expert Opin Pharmacother; 2004 Feb; 5(2):237-46. PubMed ID: 14996621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluoroquinolones in upper respiratory tract infections.
    Spiteri M
    BMJ; 1994 Mar; 308(6929):657-8. PubMed ID: 8148733
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax Tablet 200 mg), a quinolone antimicrobial].
    Tsuda H
    Nihon Yakurigaku Zasshi; 2008 Aug; 132(2):111-8. PubMed ID: 18689961
    [No Abstract]   [Full Text] [Related]  

  • 54. Fluoroquinolone treatment of skin and skin structure infections.
    Karchmer AW
    Drugs; 1999; 58 Suppl 2():82-4. PubMed ID: 10553712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The place of quinolones in everyday clinical practice.
    Moellering RC
    Chemotherapy; 1996 Mar; 42 Suppl 1():54-61. PubMed ID: 9091272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Role of therapeutic drug monitoring in pulmonary infections].
    Padoin C
    Rev Mal Respir; 2017 Jun; 34(6):693-705. PubMed ID: 28528008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in antimicrobial therapy for respiratory tract infections.
    Mushatt DM
    Curr Opin Pulm Med; 2000 May; 6(3):250-3. PubMed ID: 10782712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults.
    Moss PJ; Finch RG
    Thorax; 2000 Jan; 55(1):83-5. PubMed ID: 10607807
    [No Abstract]   [Full Text] [Related]  

  • 59. Improving adherence with antimicrobial therapy for respiratory tract infections: a discussion of directly observed therapy (DOT) and short-course therapies.
    Schwartz DB; Adler A; Dasaro AP; DeBellis RJ; Dick R; Ferro TJ; Krekun S; Malina RL; McKinnon PS; Volturo G
    Am J Ther; 2004; 11 Suppl 1():S18-21. PubMed ID: 23570158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Respiratory infections.
    Anderson EJ
    Cancer Treat Res; 2014; 161():203-36. PubMed ID: 24706226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.